Poor peripheral blood stem cell mobilization affects long-term outcomes in multiple myeloma patients undergoing autologous stem cell transplantation.

Jan S MorebMichael ByrneIlicia ShugarmanFei ZouSican XiongWilliam S MayMaxim NorkinJohn HiemenzRandall BrownChristopher CogleJohn R WingardJack W Hsu

Published in: Journal of clinical apheresis (2017)

These data indicate that poor mobilization can be predictable and is associated with more aggressive disease biology and worse outcomes, warranting intensive post-ASCT management.

Keyphrases

stem cell transplantation
peripheral blood
stem cells
patients undergoing
multiple myeloma
high dose
bone marrow
electronic health record
big data
low dose
platelet rich plasma
type diabetes
metabolic syndrome
glycemic control